vs
Beam Therapeutics Inc.（BEAM）与REPUBLIC BANCORP INC（RBCAA）财务数据对比。点击上方公司名可切换其他公司
Beam Therapeutics Inc.的季度营收约是REPUBLIC BANCORP INC的1.2倍（$114.1M vs $94.3M），Beam Therapeutics Inc.净利率更高（214.1% vs 24.2%，领先189.9%），Beam Therapeutics Inc.同比增速更快（279.5% vs 5.3%），REPUBLIC BANCORP INC自由现金流更多（$161.1M vs $-87.0M）
Beam Therapeutics是一家美国生物技术企业，专注于基因治疗与基因组编辑领域的研发，总部位于马萨诸塞州剑桥市。公司依托CRISPR碱基编辑和先导编辑技术，可通过酶促作用修改DNA序列中的单个核苷酸，且不会造成DNA双链断裂，以此开发相关治疗方案。
肯塔基州共和银行是美国的一家区域性银行控股企业，提供零售及商业银行全品类服务，涵盖个人存贷款、企业融资、按揭产品及财富管理解决方案，主要服务肯塔基州及周边州的个人消费者和中小企业客户。
BEAM vs RBCAA — 直观对比
营收规模更大
BEAM
是对方的1.2倍
$94.3M
营收增速更快
BEAM
高出274.2%
5.3%
净利率更高
BEAM
高出189.9%
24.2%
自由现金流更多
RBCAA
多$248.1M
$-87.0M
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $114.1M | $94.3M |
| 净利润 | $244.3M | $22.8M |
| 毛利率 | — | — |
| 营业利润率 | -15.3% | 29.3% |
| 净利率 | 214.1% | 24.2% |
| 营收同比 | 279.5% | 5.3% |
| 净利润同比 | 370.4% | 20.0% |
| 每股收益（稀释后） | $2.53 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收BEAMRBCAA
| Q4 25 | $114.1M | $94.3M | ||
| Q3 25 | — | $93.5M | ||
| Q2 25 | — | $93.8M | ||
| Q1 25 | — | $135.8M | ||
| Q4 24 | — | $89.5M | ||
| Q3 24 | — | $88.1M | ||
| Q2 24 | — | $86.9M | ||
| Q1 24 | — | $120.3M |
净利润BEAMRBCAA
| Q4 25 | $244.3M | $22.8M | ||
| Q3 25 | — | $29.7M | ||
| Q2 25 | — | $31.5M | ||
| Q1 25 | — | $47.3M | ||
| Q4 24 | — | $19.0M | ||
| Q3 24 | — | $26.5M | ||
| Q2 24 | — | $25.2M | ||
| Q1 24 | — | $30.6M |
营业利润率BEAMRBCAA
| Q4 25 | -15.3% | 29.3% | ||
| Q3 25 | — | 40.4% | ||
| Q2 25 | — | 43.0% | ||
| Q1 25 | — | 44.1% | ||
| Q4 24 | — | 25.8% | ||
| Q3 24 | — | 38.4% | ||
| Q2 24 | — | 37.0% | ||
| Q1 24 | — | 32.2% |
净利率BEAMRBCAA
| Q4 25 | 214.1% | 24.2% | ||
| Q3 25 | — | 31.8% | ||
| Q2 25 | — | 33.5% | ||
| Q1 25 | — | 34.8% | ||
| Q4 24 | — | 21.2% | ||
| Q3 24 | — | 30.1% | ||
| Q2 24 | — | 29.0% | ||
| Q1 24 | — | 25.4% |
每股收益（稀释后）BEAMRBCAA
| Q4 25 | $2.53 | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $1.2B | $220.0M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $1.2B | $1.1B |
| 总资产 | $1.5B | $7.0B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资BEAMRBCAA
| Q4 25 | $1.2B | $220.0M | ||
| Q3 25 | — | $484.2M | ||
| Q2 25 | — | $484.8M | ||
| Q1 25 | — | $793.0M | ||
| Q4 24 | — | $432.2M | ||
| Q3 24 | — | $530.9M | ||
| Q2 24 | — | $400.1M | ||
| Q1 24 | — | $546.4M |
股东权益BEAMRBCAA
| Q4 25 | $1.2B | $1.1B | ||
| Q3 25 | — | $1.1B | ||
| Q2 25 | — | $1.1B | ||
| Q1 25 | — | $1.0B | ||
| Q4 24 | — | $992.0M | ||
| Q3 24 | — | $979.7M | ||
| Q2 24 | — | $955.4M | ||
| Q1 24 | — | $935.6M |
总资产BEAMRBCAA
| Q4 25 | $1.5B | $7.0B | ||
| Q3 25 | — | $7.0B | ||
| Q2 25 | — | $7.0B | ||
| Q1 25 | — | $7.1B | ||
| Q4 24 | — | $6.8B | ||
| Q3 24 | — | $6.7B | ||
| Q2 24 | — | $6.6B | ||
| Q1 24 | — | $6.9B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-83.3M | $168.2M |
| 自由现金流经营现金流 - 资本支出 | $-87.0M | $161.1M |
| 自由现金流率自由现金流/营收 | -76.3% | 170.9% |
| 资本支出强度资本支出/营收 | 3.3% | 7.5% |
| 现金转化率经营现金流/净利润 | -0.34× | 7.37× |
| 过去12个月自由现金流最近4个季度 | — | $288.6M |
8季度趋势，按日历期对齐
经营现金流BEAMRBCAA
| Q4 25 | $-83.3M | $168.2M | ||
| Q3 25 | — | $33.3M | ||
| Q2 25 | — | $8.4M | ||
| Q1 25 | — | $93.2M | ||
| Q4 24 | — | $149.0M | ||
| Q3 24 | — | $51.3M | ||
| Q2 24 | — | $4.0M | ||
| Q1 24 | — | $71.2M |
自由现金流BEAMRBCAA
| Q4 25 | $-87.0M | $161.1M | ||
| Q3 25 | — | $30.8M | ||
| Q2 25 | — | $5.2M | ||
| Q1 25 | — | $91.6M | ||
| Q4 24 | — | $143.2M | ||
| Q3 24 | — | $49.8M | ||
| Q2 24 | — | $2.7M | ||
| Q1 24 | — | $69.1M |
自由现金流率BEAMRBCAA
| Q4 25 | -76.3% | 170.9% | ||
| Q3 25 | — | 32.9% | ||
| Q2 25 | — | 5.5% | ||
| Q1 25 | — | 67.4% | ||
| Q4 24 | — | 160.0% | ||
| Q3 24 | — | 56.5% | ||
| Q2 24 | — | 3.1% | ||
| Q1 24 | — | 57.5% |
资本支出强度BEAMRBCAA
| Q4 25 | 3.3% | 7.5% | ||
| Q3 25 | — | 2.6% | ||
| Q2 25 | — | 3.5% | ||
| Q1 25 | — | 1.2% | ||
| Q4 24 | — | 6.5% | ||
| Q3 24 | — | 1.7% | ||
| Q2 24 | — | 1.5% | ||
| Q1 24 | — | 1.7% |
现金转化率BEAMRBCAA
| Q4 25 | -0.34× | 7.37× | ||
| Q3 25 | — | 1.12× | ||
| Q2 25 | — | 0.27× | ||
| Q1 25 | — | 1.97× | ||
| Q4 24 | — | 7.84× | ||
| Q3 24 | — | 1.93× | ||
| Q2 24 | — | 0.16× | ||
| Q1 24 | — | 2.33× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
BEAM
| Pfizer | $109.1M | 96% |
| Other | $5.0M | 4% |
RBCAA
暂无分部数据
